Ex vivo gene transfer offers a potential means to introduce genes into cells, which may play an important role in preventing graft rejection and inducing graft tolerance. This study examined the efficiency and toxicity of several lipid-based transfection reagents (LipofectAMINE, DOTAP, and DOSPER) in intact pancreatic islets. Isolated islets were transfected with a pCMV-β-galactosidase plasmid using several DNA/liposome ratios (1:12) of liposomes (3-72 µl) and DNA (3 and 6 µg). Transfection efficiency was quantified by microscopic evaluation of β-galactosidase gene expression in whole intact islets. Functionality of the transfected islets was measured by insulin response to glucose solutions. All transfection reagents evaluated in this study transfected cells within the islets. As expected, untransfected controls and transfected islets with DNA alone did not express β-gal. The highest transfection efficiency and functional viability were obtained following a 48-h incubation after exposure to the transfection mixtures as follows: 3 µl DNA and 18 µl DOTAP/ml (1:6 ratio), 6 µg DNA and 12 µl DOSPER/ml (1:2 ratio), or 6 µg DNA and 12 µl Lipofect-AMINE/ml (1:2 ratio). The highest rate of transfected cells per islet was obtained using DOTAP. In vitro functionality was not significantly different between DOTAP and nontreated controls. However, optimal transfection efficiency doses of LipofectAMINE and DOSPER significantly reduced the stimulated insulin response of the transfected islets (p < 0.05, ANOVA). The calculated stimulation index (SI) was 7.8 ± 0.6 (mean ± SEM) for DOTAP-transfected islets compared with 8.4 ± 0.5 for nontransfected control islets (p = ns). The SI of DOSPER-and LipofectAMINE-transfected islets was significantly lower (6.1 ± 0.5 and 3.4 ± 0.5, respectively, p < 0.05). Lipid-based transfection using DOTAP at a DNA/lipid ratio of 1:6 provides an effective means of ex vivo gene delivery without compromising in vitro functionality of the transfected islets. 697 698 LAKEY ET AL.
INTRODUCTION
effective (6, 42, 51) . Specifically, islet transplantation is the alternative treatment established to correct for the Conventional insulin therapy has long been the main insulin deficiency, and possibly to effect a cure for type treatment modality for insulin-dependent (type I) diabe-I diabetes. tes mellitus (IDDM). This type of therapy encompasses β Cells in the pancreatic islets of Langerhans function regular insulin injections and intermittent blood glucose in normalizing blood sugar levels via endogenous insumonitoring. In spite of strict compliance with this theralin secretion. The destruction of these endocrine cells by peutic protocol, severe long-term complications may autoimmune attacks results in a loss of function. Allogestill arise as IDDM progresses. The instability in blood neic islet transplantation is a means to replace the deglucose levels is compensated by elevating the insulin stroyed autogeneic islet tissue and restores µ-cell dose, which eventually becomes ineffective. Ultimately, function. Studies in diabetic animal models have demondiabetic patients may go into a "hypoglycemic unawarestrated the restoration of normoglycemia with islet transness" state, or diabetic coma. The rapid fluctuation in plantation (18, 26, 56, 57) . In human studies, islet transblood glucose levels renders difficulty in prescribing an plantation has allowed a limited number of recipients to effective insulin dose. Further deterioration of IDDM experience periods of insulin independence posttranscan be prevented by current islet replacement therapy plantation in several centers worldwide (22, 28, 58, 65) . when exogenous insulin therapy is slowly becoming in-islet transplant trial involving seven brittle diabetic mentation on the use of lipofection on intact canine islets from which both the transfection efficiency and recipients (55) . To date, the recipients remain off all exogenous insulin, with no reports of rejection episodes functional integrity have been examined. Efficiency of transfection in this particular study is evaluated by the under a new immunosuppressive regimen. Key variables in this trial are the isolation of functional islets of number of whole islets expressing the β-galactosidase (β-gal) reporter gene and are stained blue. The visible high purity and transplantation of a sufficient number of islets. Despite abundant immunosuppression, trans-blue staining is a measure of positive transfection, which can result in many cells or only a few cells being trans-plant rejection and recurrence of autoimmune disease remain the major limitations in islet transplantation today fected within the islets. The real transfection efficiency should be determined from the actual number of trans- (14, 60) .
Gene therapy offers a potential means to modulate the fected cells with reporter expression rather than from whole intact islets. Because islets are composed of a het-regional immunity occurring in a transplant environment (69) . Prior to transplantation, ex vivo manipulation via erogeneous population of cells the efficiency of DNA uptake could vary between cell types and their relative introduction of functional immunomodulatory gene(s) into islets will hopefully improve the survival, function, locations within the tissue. It is also important to know what cell type is being transfected and whether transfec-and safety of these islets following transplantation into a foreign host. This ex vivo modification accomplished by tion mostly occurs in the periphery where mainly non-β cells reside or closer to the core where the majority of refined gene transfer techniques will help prolong the survival of the islet transplants. To utilize gene therapy effec-β cells are found. However, the aim of this study was to compare the relative transfection efficiency, in terms of tively, the most fundamental challenge is to find a safe and efficient gene vector (4, 9, 67) that permits a high ex-
the number of islets expressing β-gal, and toxicity level of different commercially available cationic lipid-based pression of the immunomodulatory gene(s) whose activity does not interfere with islet function. reagents in intact cultured canine islets. The reagents used were LipofectAMINE (Gibco), DOSPER (Roche), Although viral means of gene transfer are effective (19,63) in vitro, they may not be suitable in an in vivo and DOTAP (Roche). More importantly, whether toxicity of these lipid reagents had any adverse effects on transplant setting. Some limitations include reversion of the viral recombinant vector to wild-type, risk of car-islet function was assessed by determining the stimulation index (SI) that measures the insulin secretion by cinogenesis, and a potential of generating immunity against viral antigens (15, 17, 23) . Use of retroviral vector transfected islets in response to glucose stimulation. is futile due to the nonproliferative nature of mature iso-MATERIALS AND METHODS lated islets (8, 69) . Even though adenovirus infects non-Islet Isolation and Culture replicating cells this vector elicits immune responses towards the viral proteins expressed by transduced cells, Pancreases were harvested from outbred mongrel dogs using standard procurement techniques with PE-90 which are consequently eliminated by the host's immune system. This mode of transfection may also be detrimen-cannulas inserted into the main branch of the pancreas duct prior to excision (64) . The pancreas was cooled and tal to the survival of the islet graft (24) . Biosafety issues are inherent concerns with use of viral vectors in the cleaned of all fat and extraneous tissue prior to cannulation. Islets were isolated by gentle mechanical dissocia-treatment of human diseases, which makes nonviral-mediated systems an attractive alternative. tion following intraductal collagenase (Liberase, CI-Roche, prewarmed to 30°C) perfusion (27, 66) . Samples Nonviral gene transfer technologies offer some advantages over viral methods: safe, simple, ease of large-of the digest were removed and stained with dithizone to assess the progression of the dissociation. When the scale production. and the lack of immunogenicity (31, 32, 70) . Among the numerous nonviral gene delivery majority of the islets were free from the exocrine tissue the digestion phase was terminated and the chambers systems, liposome-mediated transfection is the most widely studied (49, 61) . Improved formulations of com-were flushed with cold Hanks solution that had been supplemented with 10% newborn calf serum. Purified mercial liposomes have provided higher in vitro transfection efficiency (16). They are applicable to a broad islets, separated from the exocrine tissue using a Euro-Ficoll gradient on a Cobe 2991 blood cell processor range of cell types, do not require actively dividing cells, and can achieve a stable transfection.
(46), were plated in CMRL tissue culture medium supplemented with 10% fetal calf serum (FBS) and antibiot-Nonviral transfection of isolated islets has been primarily attempted using rodent islets. Many studies have ics, and cultured overnight at 37°C. Each group of 500-1000 islets was placed in 24-well Transwell plates for shown encouraging results from gene manipulation mainly in rodent models (8, 18, 19, 56) . There is no docu-the transfection studies.
Islet Transfection standards was used to assay for the insulin content. Insulin secretion by different groups of transfected islets was Several transfection protocols were evaluated to deexpressed per islet equivalent and the SI was calculated termine the optimal protocol. Parameters evaluated inby dividing the insulin output during stimulation with cluded the dose of lipid and DNA, ratio of DNA to lipid, high glucose plus IBMX over insulin values obtained incubation time of islets in transfection mixture, and culfrom low glucose incubation. tured time prior to detection. Resultant β-gal reporter Results were expressed as the mean ± SEM. Differactivity was then determined after a period of 48-h tissue ences between the experimental groups were assessed culture at 37°C. Plasmid cDNA (vector purchased from using ANOVA with p< 0.05 considered statistically sig-Roche) encoding the β-gal gene driven by a pCMV pronificant. moter was prepared in serum-free medium (CMRL medium without serum added) with 20 mM HEPES and RESULTS diluted to the appropriate volumes for the experimental Optimization of Liposomal Transfection protocol. In a separate tube the cationic liposomal re-High amounts of toxicity resulting from lipid transagent (DOTAP and DOSPER from Roche, and Lipofectfection compromise both transfection efficiency and is-AMINE from Life Technologies) was also diluted in selet viability and function. To achieve high transfection rum-free medium. The DNA was added dropwise to the efficiency and acceptable cell survival rates the DNA/ tube containing the transfection reagent and the tubes liposome ratio must be optimized for each cell type and were incubated at room temperature for 1 h prior to platprotocol. The volumes of cationic liposome reagents ing. Islets were incubated in the prepared transfection evaluated ranged from 6 to 72 µl for DOTAP, 3 to 48 mixture for 24 h, after which the transfection mixture and 54 µl for DOSPER and LipofectAMINE, respecwas washed away with completed CMRL (constituted tively. Amounts of plasmid DNA examined were 3 and with 10% FBS and antibiotics) and islets were further 6 µg, along with the liposomal reagents to give a range cultured in completed CMRL at 37°C in a 5% CO 2 huof DNA/lipid ratios of 1:1 to 1:8. Transfected islet cells midified incubator for another 24 h. Islets were washed expressing the β-gal reporter stain dark brown to black, in Dulbecco's phosphate buffer solution (DPBS from whereas negative or untransfected cells remain clear in Life Technologies), then fixed for 15 min in 2% formalcolor ( Fig. 1 ). Positive results (islets expressing β-gal) dehyde and 0.2% glutaraldehyde in PBS solution. Islets were scored by examining groups of islets from each were then washed three additional times with DPBS and preparation to determine β-gal expression in cells within stained with an X-gal staining solution containing 4.4% the islets. 1 M HEPES, 0.3% 5 M NaCl, 0.13% MgCl 2 , 0.6% 0.5 M potassium ferricyanide, and 0.25% 200 mg/ml X-gal LipofectAMINE-Mediated Transfection of Cultured in DMP. Transfection efficiency was assessed through Intact Canine Islets β-gal expression. At least 100 islets were counted and LipofectAMINE-mediated transfection of islets rescored in duplicate by two independent investigators to sulted in the lowest efficiency among the three lipid redetermine the percentage of transfection in each experiagents examined. At a DNA/lipid ratio of 1:1 with 3 µg mental group.
plasmid DNA 15% (n = 3) of the intact islets expressed Islet Viability β-gal activity ( Table 1 ). The same DNA/lipid ratio under The in vitro functional viability of islets was detersimilar culture conditions with 6 µg of DNA yielded mined by the SI, indicative of islet function, following 33% (n = 5) of the islets with β-gal expression following transfection and culture. Following a 48-h culture, X-gal staining. Increasing the DNA/lipid ratio to 1:2 and known number of both transfected and control islets was 1:4 resulted in 21% (n = 9) and 36% (n = 9) of positive placed in transferable baskets (Corning Costar Corporaislets with β-gal expression, respectively. At 6 µg DNA, tion) that had an 8-µm screen and rinsed in prewarmed 22% (n = 10) and 34% (n = 3) of the islets were positive. RPMI solution at a glucose concentration of 2.8 mM for
Untransfected control islets did not express β-gal at all. 30 min. The basket containing the islets was rinsed then
In another control group with DNA alone no positive transferred and incubated in a low glucose solution (2.8 islets were detected at 3 and 6 µg. mM) for 60 min followed by the transfer to a high glu-
Transfection of Intact Canine Islets With DOSPER cose solution (20 mM) that had been supplemented with the insulin secretogue IBMX at a concentration of 50
Control groups of islets, both the untransfected controls and islets incubated in DNA alone, failed to trans-µm for another 60 min. After a 2-h incubation at 37°C the supernatant was removed and the insulin content was fect any cells within the islets. Peak transfection efficiency was 94% (n = 9) at a ratio of 1:4 and 3 µg DNA. assessed. A radioimmunoassay using human insulin Values are mean ± SEM.
Intact islets incubated in transfection mixtures with highest DNA/lipid ratio. Toxicity may be a cause for the decrease in gene expression observed at 6 µg DNA and DNA/lipid ratios of 1:1, 1:4, and 1:6 had β-gal activity ranging from 50 ± 25% to 94 ± 2%. At other DNA/lipid a ratio of 1:6. Both control groups (nontransfected and DNA alone groups) resulted in 0% transfection. ratios efficiencies ranged from 31 ± 3% to 55 ± 23%. Increasing the amount of DNA at these ratios failed to
Overall, higher gene expression was found with DOTAP. A DNA/lipid ratio of 1:4 appeared to be opti-increase the percent of positive islets. Likewise, increasing the lipid concentration above the optimal ratio of 1: mal for all three cationic liposomes and intact canine islets. 4 actually resulted in a smaller proportion of positive islet cells. This decrease may be a result of the toxicity In Vitro Function of Islets Transfected associated with the DOSPER reagent. Levels of β-gal With LipofectAMINE appeared much higher using DOSPER than Lipofect-Islets incubated in LipofectAMINE demonstrated AMINE at the various DNA/lipid ratios. In addition, toxicity. As concentrations of LipofectAMINE increased, more cells within the islets were expressing β-gal comtoxicity also increased, leading to reduced insulin secrepared with LipofectAMINE transfection (Fig. 1) .
tion. The calculated SI was 6.2 ± 0.4 for islets incubated at a DNA/lipid ratio of 1:1. SI continued to decrease Intact Canine Islets Transfected With DOTAP at higher DNA/lipid ratios. At the optimal transfection Highest rate of transfected cells per islet was obtained efficiency dose, SI was 3.9 ± 0.4 compared with the with DOTAP ( Fig. 1) . DNA/lipid mixtures at ratios 1:
nontransfected control, which had an SI of 8.5 ± 0.6 (p < 4, 1:5, and 1:6 were comparable to the peak efficiency 0.05, Table 2 ). SI was significantly reduced when the obtained with DOSPER. Transfection with 6 µg of plaslipid concentration exceeded 12 µl lipid. Apparently, at mid DNA at these ratios resulted in significantly higher the optimal dose of LipofectAMINE, stimulated insulin efficiencies than DOSPER. Lowest efficiency was acresponse was blunted. quired at a 1:2 ratio with 3 and 6 µg DNA. At DNA/ In Vitro Functional Assay lipid ratios of 1:4 to 1:6 expression levels were not sigfor DOSPER-Transfected Islets nificantly different between the groups. This range of ratios appeared to give optimal transfection efficiencies.
Likewise for DOSPER, insulin secretion was blunted at the optimal transfection dose. At a DNA/lipid ratio of No significant increase in efficiency was observed at the 1:4 SI was 6.1 ± 0.5 compared with the untreated control of DOTAP exceeded 36 µl. In vitro functionality of transfected islets was preserved using DOTAP. with a SI of 8.5 ± 0.6 (p < 0.05). Islets transfected with DOSPER at several other DNA/lipid ratios also showed Combined Functional Viability a reduction in SI as the concentrations of DOSPER inand Transfection Efficiency creased. Statistical significance was reached when the DNA/lipid doses exceeded 24 µl DOSPER. Like Lipo-When comparing islet function and the peak propor-fectAMINE, DOSPER appeared toxic towards islet viation of islets expressing β-gal the following graph was bility and function. created (Fig. 2 ). Whereas Figure 1 shows the optimal dose of DNA/lipid mixtures that resulted in the highest In Vitro Functions of DOTAP-Transfected Islets number of transfected islets, Figures 3 and 4 show islets transfected with doses of DNA/lipid mixtures that might DOTAP lipid reagent did not cause a similar toxicity on in vitro islet function at the levels observed using have compromised islet function. The highest SI and the highest proportion of islets expressing β-gal activity DOSPER or LipofectAMINE. At the optimal DNA/lipid ratio of 1:4, which was the optimal transfection dose for were obtained with DOTAP at a DNA/lipid ratio of 3 µg to 18 µl (1:6 ratio, Fig. 3 ). DOSPER had a SI of 6.5 all three lipid reagents, stimulated insulin response was not adversely affected. SI for DOTAP was 7.8 ± 0.6 and with 45% of islets expressing the reporter molecule at 6 µg DNA to 12 µl lipid (1:2 ratio). The fewest proportion the nontransfected control was 8.5 ± 0.6 (p = NS). No statistical significance in SI was observed. Further sig-of islets being transfected and the reagent with the highest toxicity on insulin secretion was with Lipofect-nificant reduction in SI was observed when the amount AMINE transfection at a DNA/lipid ratio of 6 µg to 12 transfection parameters to give both high efficiency and cell viability. µl (1:2 ratio, Fig. 4 ). Exocrine tissues were also present in the islet cultures as shown in Figures 3 and 4 , and DISCUSSION they could be mistaken for disintegrated islets. Actual islets have a round and healthy appearance. This com-Islet cell replacement through pancreas transplantation has been the practical therapeutic approach for bined assay highlights the importance of optimization of treating progressive IDDM prior to the advent of islet (25) . Unfortunately, the scarcity of transplantable tissue, recurrence of autoimmunity, and allograft rejection are tissue transplantation. A pancreas transplant has been shown to successfully restore "normal" blood glucose all factors limiting the development of clinical islet transplantation as a therapy in the treatment of insulin-level (6, 59, 69) . Exogenous insulin supplementation is no longer necessary; however, substantial immunosuppres-dependent diabetes mellitus (69) . Immunological reactions remain a major obstacle that sion is administered to prevent transplant rejection. Unfortunately, the abundant immunosuppression may not may be surmounted by gene therapy. Gene transfer techniques have been used to modify host immunoreactivity always deter the course and incidence of immune rejection episodes (6) . Organ shortage, the great level of dif-and induce graft tolerance. However, the efficacy of immunomodulation remains inconclusive at this time. ficulty underlining the surgical procedure, and the associated high procedural costs have limited a broader Gainer et al. showed that biolistically transfected islets with CTLA4-Ig had resulted in prolonged allograft sur-application of pancreas transplantation (25) . Due to these drawbacks, replacement with islet tissue trans-vival (18) . A similar finding was observed by Lenschow et al. (31) . Furthermore, intact canine islets transduced plants is beginning to gain momentum as a feasible treatment alternative and a potential cure for insulin-with immunosuppressive cytokine genes, IL-10 and TGF-β, improved early graft function and prolonged xe-dependent diabetes.
Insulin-dependent diabetes mellitus is characterized nograft survival in rat recipients (10, 11) . Other studies, however, have shown that immunomodulation had not by the hyperglycemia resulting from the autoimmune destruction of insulin-producing β cells centrally located benefited graft survival. Smith et al. found that IL-10 failed to prevent recurrent autoimmune disease in synge-in the islets of Langerhans. Theoretically, the hyperglycemic state can be reverted by the implantation of func-neic NOD mice (57). This is also true for the IL-4 cytokine (57). Interestingly, contrasting results were ob-tional islets. The number of islets needed to restore normoglycemia is small compared with a whole pancreas tained by Mueller's group, who used a transgenic NOD mice model that expressed IL-4; they found that these transplant and so the amount of immunosuppression required is reduced. Islet transplantation is a simpler sur-NOD-IL-4 mice did not develop insulitis and diabetes (38) . Several other studies also showed failure of im-gery with reduced perioperative morbidity and mortality planted islets bearing either Fas ligand (Fas L) alone or viral-mediated vector systems are consistently being investigated. Nonviral vectors are nonimmunogenic and co-implanted with myoblasts bearing this specific molecule (24, 40, 62) . Fas L constitutively expressed in im-nonpathogenic. They transfect a wide variety of cell types, both dividing and nondividing cells (9) . Gene ex-mune privileged sites is believed to play a role in the induction of immune tolerance at these sites. Fas L-ex-pression, however, is transient and usually low compared with viral methods (1, 34) . Efficiency of transfec-pressing cells are protected from immune destruction by inducing apoptosis of nearby activated cytotoxic T cells tion with calcium phosphate and DEAE-dextran is not very impressive (16,50,52) . The majority of the plasmid bearing Fas. Surprisingly, Muruve et al. found that pancreatic islet iso-and allografts expressing Fas L resulted DNA is being degraded in the endo-lysosomal compartment when endocytosed (36, 49, 53, 54, 68) . Other nonvi-in apoptosis (40) . Fas L-expressing islets were destroyed, leading to reduced graft survival in a murine ral means of gene transfer include electroporation (47) and biolistics (or the gene gun approach) (2) . Few re-transplant model. β cells can acquire Fas expression upon T-cell induction, thereby undergoing apoptosis as ports have shown that these physical transfer methods offer a higher transfection efficiency (20,21,39). Both well (7) . Whether Fas L enhances islet survival remains controversial. Lau et al. found that Fas L prolonged islet biolistics and electroporation are more damaging to cells. The cell membrane is momentarily punctured by graft survival in the absence of neutrophilic infiltration (29) , whereas in other studies cellular infiltration was the huge pressure or voltage applied and plasmid DNA is taken up through the pores directly into the cytosol, observed at the engrafted site. A possible explanation for the observed cellular infiltration may be related to and the membrane is later sealed. Through this route of DNA entry, plasmid DNA escapes the endo-lysosomal the use of adenovector for ex vivo gene delivery into pancreatic islets and the inflammatory infiltrate may compartment where DNA is enzymatically degraded. Resultant transfection efficiency with these methods play a pathogenic role in β-cell destruction.
Most studies that resulted in high efficiency of trans-would be greater than the classical chemical means. To make use of these methods, specialized apparatuses and fection adopted adenovector for gene delivery into mammalian cells. This viral approach is chosen for its pro-optimization of the biological and mechanical parameters for each cell type application are required (2, 52) . miscuity in cell types and unnecessary cell proliferation for high rates of infection (9) . Unlike adenovirus, retro-Optimization of the transfection parameters is crucial in lipofection too (52) . Some studies have indicated that virus infects only mitotic cells, which makes it an unsuitable vector for islet transduction because islets are biolistics and electroporation are more efficient than lipofection (19, 21, 39) . This all depends on the applied ex-mainly a nonreplicating tissue. Long-term stable gene expression could be attained with retroviral vector fol-perimental conditions, including the cell type used, degree of optimization, and choice of lipid-based reagent. lowing chromosomal integration, which has inherent risk of insertional mutagenesis (43, 48) . Spontaneous in-Guo et al. demonstrated 80% β-gal expression in rat islets using the gene gun at 250 psi, at which 82% of the activation of the LTR promoter can lead to a reduced gene expression in vivo (9) . Retroviral vector can also islets were recovered (20). This fairly high islet recovery rate was not found in the study done by Gainer et al., be inactivated by serum components (9, 43) . Attempts to modify the viral capsid to enhance targeting specificity who utilized greater pressures (1000 and 1200 psi) and more islets (19). This latter study concluded that biolis-and transduction efficiency in vivo have limited success (44, 45) . These are limiting factors for the use of this tics perform better than lipofection. Gainer et al. used 6 µl LipofectAMINE and 2 µg DNA for transfection of vector for long-term in vivo applications.
The widespread use of adenovirus in many eukaryo-mouse islets. They claimed that efficiency was low using lipofection compared with the gene gun and adeno-tic systems is related to its superiority in gene transfer than most vector systems (8, 19) . However, adenovectors virus, but the results were less reproducible with these latter two methods. Our study found that a DNA/Lipo-initiate immune responses towards transduced cells expressing the viral proteins, therefore prohibiting its re-fectAMINE ratio of 1:4 had resulted in efficient DNA uptake. When combined islet viability and transfection peated administration. The augmented immunogenicity causes both a primary nonfunction and a decrease in is-efficiency were at a DNA/LipofectAMINE ratio of 1: 2, approximately 25% islets stained positive and islet let allograft survival in vivo (24, 62) . Cellular infiltrates were observed in several transplant models using adeno-function was preserved (Fig. 2 ). The differences in animal model and DNA/lipid ratio used in our study and viral transduction (24, 40, 62) . Viral-mediated gene transfer, particularly adenovectors, into islet cells has appar-by Gainer et al. may have accounted for the dissimilar results. ent weaknesses and in some cases may be detrimental (5) in a transplant setting.
The LipofectAMINE reagent was found to be the least effective in our study. In contrast, Saldeen et al. With these setbacks underlining viral vector use, non-showed that the highest reporter activity was obtained cilitate plasmid DNA uptake into cells. Cell membrane fusion avoids the imminent endo-lysosomal pathway with LipofectAMINE used on dispersed human, mouse, and rat islets than other methods such as calcium phos-dominant in endocytosis. Cationic lipids can disrupt the endosome via lipid-organelle membrane fusion directly phate and Lipofectin (50) . However, they obtained negligible results with intact cultured and freshly isolated releasing the DNA into the cytosol prior to DNA degradation by nucleases in the lysosomes (68) . Although pH-islets. The dispersion may increase the accessibility of islet cells to the lipid reagent and yet only the peripheral sensitive liposomes have been formulated to disintegrate the endosome prior to lysosomal fusion, efficiency is cells within the intact islets, mainly the α cells, were transfected. Saldeen et al. did not examine the in vitro lower than cationic liposomes (30, 49) .
With the advent of gene transfer technologies, islet functional viability of the different islet groups transfected with various lipid reagents. According to Shigalla cells can be modified ex vivo to induce graft acceptance and prevent rejection in the transplant environment. et al., islets dispersed in culture had decreased viability leading to poor outcomes in a transplant model (56).
Other than manipulating regional immunity, nonislet cells can be engineered to replace normal functions of β Islet functional viability was maintained with DOTAP transfection, whereas DOSPER-and LipofectAMINE-cells in islets (33, 41) . β cells in transplanted allogeneic tissue remain a target of autoimmunity and this high sus-transfected islets demonstrated reduced SIs upon glucose stimulation compared with the control islet groups ceptibility is an inevitable risk of graft failure. To remedy this, islets can be protected against immune-medi-at optimal transfection efficiency dose in our study. The decreased viability was associated with the increased ated dysfunction by encapsulation, a technique under intensive research (35, 51) . Moreover, gene therapy now toxicity of the latter two lipid reagents. Findings by Bell et al. also supported our observation that Lipofect-provides the means to create insulin-producing nonislet cells responsive to a glucose challenge via proper insulin AMINE was more cytotoxic than DOTAP (3). DOTAP gave higher transfection efficiency and it also did not secretion, thereby fulfilling the role of β cells in islets.
To engineer other cell types or insulinoma, cell lines to adversely affect islet integrity in vitro after a 48-h culture period. Unfortunately, the time course of β-gal ex-serve as a "glucostat" that is able to maintain tight glucose control remains a major challenge in diabetes re-pression was not followed post-48-h culture. Perhaps βgal expression could last longer than 48 h; however, islet search today (12, 13, 42) . viability and function might be further compromised CONCLUSION when cultured for an extended period. Both DOTAPtransfected and, to a lesser extent, DOSPER-transfected In summary, improved formulations of liposomes are efficient tools of gene delivery for ex vivo modification islets revealed greater than 40% combined viability and efficiency (Fig. 2) . In terms of transfection efficiency of intact canine islets. Levels of β-gal activity expressed in intact islets were indicative of the efficacy of liposo-alone, DOSPER-and DOTAP-transfected canine islets had 80-94% β-gal reporter activity at the optimal DNA/ mal vectors. In addition, ex vivo manipulation of islets did not appear to adversely affect islet integrity in vitro. lipid ratio, whereas the number of LipofectAMINEtransfected islets was significantly less (36%). Visible DOTAP appeared to have the best performance with minimal toxicity and relatively high transfection effi-blue staining occurred mostly on the surface of the islet. It is difficult to assess whether the inner core of the islet ciency and functional viability. Higher toxicity levels were found with DOSPER and LipofectAMINE, which is transfected with β-gal staining alone. Tissue sections of the islet from which immunohistochemical staining appeared to have adverse effects on islet function in vitro. When selecting a safe and efficient gene vector could be done are needed to determine precisely the cell type and location of transfection. Alternatively, a differ-system, both functional viability and transfection efficiency are crucial factors, and one factor should not ent reporter such as the enhanced green fluorescent protein (EGFP) could be used along with confocal micros-compromise the other. DOTAP appeared to meet both requirements. cropy to examine the depth of transfection within the islet. Furthermore, flow cytometry could be performed
In future studies we will examine the transfection efficiency and functionality of intact as well as enzymati-on EGFP-expressing cells to determine the exact number of islet cells that have been enzymatically dispersed into cally dispersed human islets in culture following liposomal transfection. Due to the successful transfection of single cells, being truly transfected as an indication of the real transfection efficiency. Many studies have used intact canine islets with DOTAP, the efficacy of this lipid reagent will be further examined in human islets. the β-gal or luciferase gene for reporting efficiency of transfection (8, 19, 20, 30) . Our study also utilized one of In addition, we will attempt to identify the cells within the islet expressing β-gal and the duration of transgene these common reporter proteins instead of secretory proteins. All three lipid reagents used in our study are cat-expression will also be evaluated. Furthermore, in vivo transplant studies in diabetic nude mice will be per-ionic liposomes that fuse with the cell membrane to fa-19. Gainer 
